StreetAlpha.app
Home › Stocks › FHTX

Foghorn Therapeutics Inc. (FHTX)

$1.72
▼ −3.37%
LAST CLOSE · NOV 20

Foghorn develops cancer drug candidates that target the chromatin regulatory system, which controls how genes are turned on and off. It last closed at $1.72 on Nov 20, down 3.37% on the day. The next earnings report for FHTX is expected around Mon, Jan 11, 2027. For the quarter ended Sep 2026, FHTX reported EPS of $0.80 on revenue of $83.5M, with revenue up 924.7% from a year ago. Over its last 8 reports the stock moved an average of 11.4% the session after earnings.

AI Auto Pilots
Is FHTX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold FHTX.

Key Stats

Last 12 months
Results
Revenue
$112.1M
+357.3% vs a year ago
Net income
$9.4M
8.4% margin
EPS (diluted)
$0.09
Free cash flow
−$83.7M
−74.6% margin
Valuation
Market cap
$103.1M
60.0M shares
P/E
19.1
Price over 12 month EPS
Price to sales
0.9
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$80.3M
At Sep 30
Shareholder equity
−$14.1M
Shares outstanding
60.0M
At Oct 30
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $1.3M$1.3MFY2021FY2022: $19.2M$19.2MFY2022FY2023: $34.2M$34.2MFY2023FY2024: $22.6M$22.6MFY2024FY2025: $30.9M$30.9MFY2025

From FHTX's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 9). Last 12 months adds up the four latest quarters.

Next report
Jan 11
Estimated date · Time not announced
Reported EPS
$0.80
Quarter ended Sep 2026
Year ago EPS
-$0.25
Same quarter last year
Revenue
$83.5M
+924.7% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$0.30Dec '24Mar 2025: -$0.30Mar '25Jun 2025: -$0.28Jun '25Sep 2025: -$0.25Sep '25Dec 2025: -$0.34Dec '25Mar 2026: -$0.29Mar '26Jun 2026: -$0.10Jun '26Sep 2026: $0.80Sep '26Latest $0.80
Revenue by quarter
Dec 2024: $2.9MDec '24Mar 2025: $6.0MMar '25Jun 2025: $7.6MJun '25Sep 2025: $8.2MSep '25Dec 2025: $9.2MDec '25Mar 2026: $3.3MMar '26Jun 2026: $16.1MJun '26Sep 2026: $83.5MSep '26Latest $83.5M
How FHTX moved after its last 8 reports
Average move the session after a report ±11.4%
Nov 9, 2026Time not announced+9.1%
Aug 6, 2026Time not announced+14.1%
May 7, 2026Time not announced−10.3%
Mar 11, 2026After the close−12.9%
Jan 12, 2026Time not announced+23.6%
Nov 5, 2025Time not announced+13.3%
Aug 5, 2025Time not announced−2.7%
May 14, 2025Time not announced−5.1%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on FHTXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on FHTX
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on FHTX

Technical Analysis

FHTX · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold

The stock is 15% below its 20 day and 45% below its 50 day average. It is 157% below its 200 day average, so the longer trend is down. Momentum is fading (RSI 32), near oversold. The nearest support is the 52 week low at $1.66, and the nearest resistance the Pivot at $1.73.

Short trendBearish
Long trendBearish
MomentumFading
StretchNear oversold
VolatilityHigh, 10.1%/day
Key levels
$7.6152 week high+342.4%
$4.42200 day average+157.0%
$4.06100 day average+136.0%
$2.5050 day average+45.3%
$2.10Swing high (Oct 21)+22.1%
$1.9820 day average+15.1%
$1.79Pivot R1+4.1%
$1.73Pivot+0.6%
$1.72Last close
$1.6652 week low−3.5%
$1.65Pivot S1−4.1%
Indicators
RSI (14)32.31Weak, oversold below 30Neutral
MACD-0.20Above its signal lineBullish
Stochastic9.9Near the bottom of its rangeOversold
ADX (14)34.4Trending down
Williams %R-90.3Oversold below −80, overbought above −20Oversold
CCI (20)-151.6Oversold below −100, overbought above 100Oversold
Rate of change−8.0%Change over 10 sessionsBearish
ATR (14)$0.17Typical daily range, 10.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for FHTX

What happened before

See how FHTX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow FHTX usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How FHTX has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2020.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for FHTXHow many large options trades hit FHTX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

FHTX Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bullish
Strongly bearishNeutralStrongly bullish
  • ▲73 buying vs 35 selling
  • ▲Held by funds +3.6 pts
  • ▲Funds holding +19
  • ▲Superinvestors: 3 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding122103+18.4%
In funds' top 10220.0%
Held by funds78.6%74.9%+3.6 pts
New / increased29 / 4414 / 39+37.7%
Reduced / sold out25 / 1025 / 14−10.3%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See FHTX institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether FHTX is in one of them and how their past FHTX trades turned out.

FHTX in the AI portfolios
Loading…

FHTX News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered FHTX in an article yet. Here's the latest on the wider market.

FHTX in the news

About Foghorn Therapeutics

Foghorn is a biotechnology company that develops drug candidates for cancer by targeting the chromatin regulatory system, the set of cellular components that control whether genes are switched on or off. Its lead candidate, FHD-909, is an oral medicine that blocks SMARCA2 and is being developed with the pharmaceutical company Eli Lilly. The company's end users are patients with cancer, and it is based in Cambridge, Massachusetts. It uses a proprietary platform called Gene Traffic Control to identify and test new drug targets.

Headquarters
Cambridge, MA